Arne Christiaens
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Arne Christiaens has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Kris Vleminckx
Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium
2 shared publications - Attila Placido Sachslehner
Department of Dermatology, Medical University of Vienna, Vienna, Austria
1 shared publication - Bahar Golabi
Department of Dermatology, Medical University of Vienna, Vienna, Austria
1 shared publication - David Creytens
Department of Pathology, Ghent University Hospital, Ghent University, Ghent, Belgium
1 shared publication - Dieter Tulkens
Ghent University
1 shared publication - Julia Steinbinder
Department of Dermatology, Medical University of Vienna, Vienna, Austria
1 shared publication
Latest Publications
- Open Access
- 10 November 2026
- Published by Springer Nature in Scientific Reports
Transglutaminase 1 is conserved in amphibians and required for membrane-associated transglutaminase activity in the epidermis of clawed frogs
Transglutaminase 1 (TGM1) plays a central role in the cross-linking of proteins during the cornification of the epidermis in mammals. Mutations of human TGM1 lead to TGM1-nonsyndromic epidermal differentiation disorder (TGM1-nEDD), and the deletion of Tgm1 is lethal in the mouse. Here, we investigated whether the role of TGM1 is conserved in the western clawed frog ( Xenopus tropicalis ), a model species for amphibians. We found that a tgm1 gene is conserved in the three main clades of amphibians, namely anurans, caudates and caecilians. The amino acid residues implicated in catalytic activity and palmitoylation-dependent membrane anchorage are conserved in amphibian Tgm1 proteins. tgm1 is expressed besides multiple homologs of tgm3 in the skin of X. tropicalis . CRISPR-Cas9-mediated disruption of tgm1 abolished the cell membrane-associated TGM activity in the epidermis of X. tropicalis . In contrast to mosaic mutants and heterozygous mutants of tgm1 , compound heterozygous frogs carrying two predicted loss-of-function alleles of tgm1 died around metamorphosis. In conclusion, Tgm1 is catalytically active at keratinocyte cell membranes during epidermal cornification of X. tropicalis . The conservation of this role of Tgm1 in frogs and mammals supports the hypothesis that Tgm1-dependent cornification evolved in a common ancestor of amphibians and amniotes.
- 10 November 2026
- Published by Springer Nature in Scientific Reports
Open AccessTransglutaminase 1 is conserved in amphibians and required for membrane-associated transglutaminase activity in the epidermis of clawed frogs
Transglutaminase 1 (TGM1) plays a central role in the cross-linking of proteins during the cornification of the epidermis in mammals. Mutations of human TGM1 lead to TGM1-nonsyndromic epidermal differentiation disorder (TGM1-nEDD), and the deletion of Tgm1 is lethal in the mouse. Here, we investigated whether the role of TGM1 is conserved in the western clawed frog ( Xenopus tropicalis ), a model species for amphibians. We found that a tgm1 gene is conserved in the three main clades of amphibians, namely anurans, caudates and caecilians. The amino acid residues implicated in catalytic activity and palmitoylation-dependent membrane anchorage are conserved in amphibian Tgm1 proteins. tgm1 is expressed besides multiple homologs of tgm3 in the skin of X. tropicalis . CRISPR-Cas9-mediated disruption of tgm1 abolished the cell membrane-associated TGM activity in the epidermis of X. tropicalis . In contrast to mosaic mutants and heterozygous mutants of tgm1 , compound heterozygous frogs carrying two predicted loss-of-function alleles of tgm1 died around metamorphosis. In conclusion, Tgm1 is catalytically active at keratinocyte cell membranes during epidermal cornification of X. tropicalis . The conservation of this role of Tgm1 in frogs and mammals supports the hypothesis that Tgm1-dependent cornification evolved in a common ancestor of amphibians and amniotes.
- Open Access
A CRISPR-based Xenopus tropicalis model for retroperitoneal liposarcoma with genetic control over the dedifferentiation process
Well- and dedifferentiated liposarcomas (WDLPS and DDLPS) are characterized by extensive copy-number alterations rather than recurrent gene-inactivating mutations, obscuring the molecular mechanisms that drive disease progression and, critically, the transition from well-differentiated to the more aggressive dedifferentiated tumor states. Despite marked differences in clinical behavior and prognosis, the regulatory events underlying adipocytic lineage destabilization in DDLPS remain poorly understood. Here, we establish an in vivo model of retroperitoneal liposarcoma in Xenopus tropicalis through early embryonic mosaic perturbation of p53 and Rb pathway components. Combined disruption reproducibly induced retroperitoneal WDLPS development, demonstrating that pathway-level deregulation of the MDM2-p53 and CDK4-Rb axes is sufficient to initiate liposarcoma development in vivo . Strikingly, additional perturbation of transcriptional co-activator ep300 in this context resulted in increased tumor dedifferentiation, yielding lesions composed of spatially coexisting well- and dedifferentiated adipocytic states. In contrast, direct targeted disruption of downstream adipogenic regulators recurrently lost in human DDLPS, including cebpa , g0s2 , and dgat2 , failed to induce dedifferentiation in the same genetic context in vivo . These findings indicate that dedifferentiation cannot be explained by loss of downstream adipocytic effectors alone but instead reflects destabilization of higher-order regulatory programs governing adipocytic identity. Together, these results establish an in vivo model that closely reflects the clinical situation on a pathway level and provides initial mechanistic insight into how adipocytic differentiation may become destabilized during disease progression. This framework offers a foundation for future studies leveraging higher-order and multi-omic approaches to dissect the molecular processes underlying the WDLPS-to-DDLPS transition.
Open AccessA CRISPR-based Xenopus tropicalis model for retroperitoneal liposarcoma with genetic control over the dedifferentiation process
Well- and dedifferentiated liposarcomas (WDLPS and DDLPS) are characterized by extensive copy-number alterations rather than recurrent gene-inactivating mutations, obscuring the molecular mechanisms that drive disease progression and, critically, the transition from well-differentiated to the more aggressive dedifferentiated tumor states. Despite marked differences in clinical behavior and prognosis, the regulatory events underlying adipocytic lineage destabilization in DDLPS remain poorly understood. Here, we establish an in vivo model of retroperitoneal liposarcoma in Xenopus tropicalis through early embryonic mosaic perturbation of p53 and Rb pathway components. Combined disruption reproducibly induced retroperitoneal WDLPS development, demonstrating that pathway-level deregulation of the MDM2-p53 and CDK4-Rb axes is sufficient to initiate liposarcoma development in vivo . Strikingly, additional perturbation of transcriptional co-activator ep300 in this context resulted in increased tumor dedifferentiation, yielding lesions composed of spatially coexisting well- and dedifferentiated adipocytic states. In contrast, direct targeted disruption of downstream adipogenic regulators recurrently lost in human DDLPS, including cebpa , g0s2 , and dgat2 , failed to induce dedifferentiation in the same genetic context in vivo . These findings indicate that dedifferentiation cannot be explained by loss of downstream adipocytic effectors alone but instead reflects destabilization of higher-order regulatory programs governing adipocytic identity. Together, these results establish an in vivo model that closely reflects the clinical situation on a pathway level and provides initial mechanistic insight into how adipocytic differentiation may become destabilized during disease progression. This framework offers a foundation for future studies leveraging higher-order and multi-omic approaches to dissect the molecular processes underlying the WDLPS-to-DDLPS transition.